Literature DB >> 1319278

Correlation between calmodulin-like protein, phospholipids, and growth in glucose-grown Mycobacterium phlei.

P H Reddy1, S S Burra, P S Murthy.   

Abstract

In Mycobacterium phlei TMC 1548 supplementation of growth medium containing 2% v/v glycerol with glucose (up to 5% w/v) resulted in an increase in growth (yield of cells), in amount of total phospholipids, and in each of the individual phospholipids (cardiolipin, phosphatidylethanolamine, phosphatidylinositol and its mannosides, and phosphatidylglycerol). However, when the medium was supplemented with a higher concentration (7.5% w/v) of glucose, both growth and phospholipid levels decreased to near control values (2% v/v glycerol alone). Cyclic AMP levels, which decreased at all concentrations of glucose, had no relation to phospholipid content or growth. The presence of a protein that possesses the property of stimulating c-AMP phosphodiesterase activity was recently demonstrated in Mycobacterium smegmatis (Falah et al. 1988. FEMS Microbiol. Lett. 56: 89-93). In M. phlei the level of this calmodulin-like protein (assayed by radioimmunoassay) changed with different concentrations of glucose in the growth medium in a manner identical with that of phospholipids. We suggest that in mycobacteria (i) intracellular calmodulin-like protein levels are affected by glucose concentration in the growth medium and (ii) there is a positive correlation between the levels of calmodulin-like protein, total and individual phospholipids, and growth (yield of cells) in glucose-grown M. phlei.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1319278     DOI: 10.1139/m92-057

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  9 in total

Review 1.  Interrelation of Ca2+ and PE_PGRS proteins during Mycobacterium tuberculosis pathogenesis.

Authors:  Laxman S Meena
Journal:  J Biosci       Date:  2019-03       Impact factor: 1.826

Review 2.  Thioridazine: resurrection as an antimicrobial agent?

Authors:  H K R Thanacoody
Journal:  Br J Clin Pharmacol       Date:  2007-08-31       Impact factor: 4.335

3.  Natural products from the termite Nasutitermes corniger lowers aminoglycoside minimum inhibitory concentrations.

Authors:  Henrique D M Coutinho; Alexandre Vasconcellos; Hilzeth L Freire-Pessôa; Carlos A Gadelha; Tatiane S Gadelha; Geraldo G Almeida-Filho
Journal:  Pharmacogn Mag       Date:  2010-02-13       Impact factor: 1.085

4.  Trifluoperazine and CEF-allicin from garlic (Allium sativum) as potential new antitubercular drugs active against drug resistantMycobacterium tuberculosis.

Authors:  P S Murthy; P Ratnakar; D V Gadre; V Talwar; H C Gupta; R L Gupta
Journal:  Indian J Clin Biochem       Date:  1997-12

5.  Cloning and expression of the gene for a novel protein from Mycobacterium smegmatis with functional similarity to eukaryotic calmodulin.

Authors:  Prasad T Reddy; C Rama Prasad; P Hemalatha Reddy; Dennis Reeder; Keith McKenney; Howard Jaffe; Mariana N Dimitrova; Ann Ginsburg; Alan Peterkofsky; P Suryanarayana Murthy
Journal:  J Bacteriol       Date:  2003-09       Impact factor: 3.490

6.  Role of cyclic adenosine monophosphate in phospholipid synthesis in Mycobacterium smegmatis ATCC 607.

Authors:  H Kaur; G K Khuller
Journal:  Lipids       Date:  1995-04       Impact factor: 1.880

7.  Calmodulin-like protein from M. tuberculosis H37Rv is required during infection.

Authors:  Meeta J Advani; Malini Rajagopalan; P Hemalatha Reddy
Journal:  Sci Rep       Date:  2014-10-31       Impact factor: 4.379

8.  Antimicrobial Peptide K11 Selectively Recognizes Bacterial Biomimetic Membranes and Acts by Twisting Their Bilayers.

Authors:  Francisco Ramos-Martín; Claudia Herrera-León; Viviane Antonietti; Pascal Sonnet; Catherine Sarazin; Nicola D'Amelio
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-22

9.  Termite usage associated with antibiotic therapy: enhancement of aminoglycoside antibiotic activity by natural products of Nasutitermes corniger (Motschulsky 1855).

Authors:  Henrique D M Coutinho; Alexandre Vasconcellos; Micheline A Lima; Geraldo G Almeida-Filho; Rômulo R N Alves
Journal:  BMC Complement Altern Med       Date:  2009-09-17       Impact factor: 3.659

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.